// App-Quantinova.ai

13108 2014 AHA : Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation for Off-Label vs. On-Label Indications

Researchers

Presenter

  • Jung-Min Ahn

Principal Investigators

  • Cheol Whan Lee

  • Jong-Young Lee

  • Soo-Jin Kang

  • Seung-Whan Lee

  • Young-Hak Kim

  • Seong-Wook Park

  • Seung-Jung Park

  • Sung-Cheol Yun

  • Sung-Han Yoon

  • Hyun Woo Park

  • Mineok Chang

  • Pil Hyung Lee

  • Hyo In Choi

  • Jae-Hyung Roh

  • Hanul Choi

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Renal insufficiency

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved